New Pharmacy Transparency Requirements Reach Plan Sponsors Too

Federal reforms are putting plan sponsors’ oversight duties in sharper focus. The 2026 Consolidated Appropriations Act (signed February 3) adds PBM reporting rules that cover drug spending, pass-through rebates, and vendor compensation. Major provisions will generally...

Over 350 Brand-Name Drugs See a Price Increase in 2026

Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...